Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03030833 · ClinicalTrials.gov registry record
Dysfunctional Hemoglobin Pulse Oximetry
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 36
- Enrollment target
NCT03030833: Completed study, sponsored by Nonin Medical.
NCT03030833 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03030833 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to assess device performance in the presence of carbon monoxide.
Primary Outcome
Values from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.
Interventions
- DEVICE Pulse Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2017-04-30 |
What the finished NCT03030833 record still lists
NCT03030833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse Oximeter is the first listed.
NCT03030833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03030833 about?
NCT03030833 is a clinical study titled "Dysfunctional Hemoglobin Pulse Oximetry". The purpose of the study is to assess device performance in the presence of carbon monoxide.
What is the current status of trial NCT03030833?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2017-02-06. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT03030833?
The interventions under investigation include: Pulse Oximeter (DEVICE).
Who is sponsoring clinical trial NCT03030833?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI